{"version":"1.0","provider_name":"All About Cardiovascular System and Disorders","provider_url":"https:\/\/johnsonfrancis.org\/professional","author_name":"Johnson Francis","author_url":"https:\/\/johnsonfrancis.org\/professional\/author\/jf\/","title":"How SGLT2 Inhibition Improves Heart Failure: Key Mechanisms - All About Cardiovascular System and Disorders","type":"rich","width":600,"height":338,"html":"<blockquote class=\"wp-embedded-content\" data-secret=\"5aLAq76IwV\"><a href=\"https:\/\/johnsonfrancis.org\/professional\/how-sglt2-inhibition-improves-heart-failure-key-mechanisms\/\">How SGLT2 Inhibition Improves Heart Failure: Key Mechanisms<\/a><\/blockquote><iframe sandbox=\"allow-scripts\" security=\"restricted\" src=\"https:\/\/johnsonfrancis.org\/professional\/how-sglt2-inhibition-improves-heart-failure-key-mechanisms\/embed\/#?secret=5aLAq76IwV\" width=\"600\" height=\"338\" title=\"&#8220;How SGLT2 Inhibition Improves Heart Failure: Key Mechanisms&#8221; &#8212; All About Cardiovascular System and Disorders\" data-secret=\"5aLAq76IwV\" frameborder=\"0\" marginwidth=\"0\" marginheight=\"0\" scrolling=\"no\" class=\"wp-embedded-content\"><\/iframe><script>\n\/*! This file is auto-generated *\/\n!function(d,l){\"use strict\";l.querySelector&&d.addEventListener&&\"undefined\"!=typeof URL&&(d.wp=d.wp||{},d.wp.receiveEmbedMessage||(d.wp.receiveEmbedMessage=function(e){var t=e.data;if((t||t.secret||t.message||t.value)&&!\/[^a-zA-Z0-9]\/.test(t.secret)){for(var s,r,n,a=l.querySelectorAll('iframe[data-secret=\"'+t.secret+'\"]'),o=l.querySelectorAll('blockquote[data-secret=\"'+t.secret+'\"]'),c=new RegExp(\"^https?:$\",\"i\"),i=0;i<o.length;i++)o[i].style.display=\"none\";for(i=0;i<a.length;i++)s=a[i],e.source===s.contentWindow&&(s.removeAttribute(\"style\"),\"height\"===t.message?(1e3<(r=parseInt(t.value,10))?r=1e3:~~r<200&&(r=200),s.height=r):\"link\"===t.message&&(r=new URL(s.getAttribute(\"src\")),n=new URL(t.value),c.test(n.protocol))&&n.host===r.host&&l.activeElement===s&&(d.top.location.href=t.value))}},d.addEventListener(\"message\",d.wp.receiveEmbedMessage,!1),l.addEventListener(\"DOMContentLoaded\",function(){for(var e,t,s=l.querySelectorAll(\"iframe.wp-embedded-content\"),r=0;r<s.length;r++)(t=(e=s[r]).getAttribute(\"data-secret\"))||(t=Math.random().toString(36).substring(2,12),e.src+=\"#?secret=\"+t,e.setAttribute(\"data-secret\",t)),e.contentWindow.postMessage({message:\"ready\",secret:t},\"*\")},!1)))}(window,document);\n\/\/# sourceURL=https:\/\/johnsonfrancis.org\/professional\/wp-includes\/js\/wp-embed.min.js\n<\/script>\n","thumbnail_url":"https:\/\/johnsonfrancis.org\/professional\/wp-content\/uploads\/2026\/06\/How-SGLT2-Inhibition-Improves-Heart-Failure-Key-Mechanisms.jpg","thumbnail_width":1280,"thumbnail_height":719,"description":"The cardioprotective benefits of SGLT2 inhibitors (like empagliflozin and dapagliflozin) have fundamentally shifted heart failure management. While initially designed for glycemic control, their profound efficacy in both HFrEF and HFpEF operates largely independently of insulin or glucose lowering. Instead, they act through a cascade of pleiotropic mechanisms that fundamentally alter cardiac loading, myocardial metabolism, and [&hellip;]"}